Inhibitors of Ribonucleic Acid Synthesis in Saccharomyces cerevisiae: Decay Rate of Messenger Ribonucleic Acid
AUTOR(ES)
Tønnesen, T.
RESUMO
Daunomycin and ethidium bromide, two deoxyribonucleic acid-intercalating drugs, inhibit ribonucleic acid (RNA) and protein synthesis in Saccharomyces cerevisiae. Both agents rapidly curtail uptake of radioactive adenine, whereas the kinetics of radioactive leucine uptake after drug addition are consistent with translation of a pool of exponentially decaying messenger RNA. Messenger RNA half-life determinations from these experiments gave identical results over a range of drug concentrations; this value is 21 ± 4 min at 30 C. In a temperature-sensitive mutant in which RNA synthesis is curtailed at the nonpermissive temperature, a similar half-life for messenger RNA decay is found both in the absence and in the presence of either drug. This indicates that at the concentrations used in this study, neither daunomycin nor ethidium bromide has an appreciable direct effect on translation and do not increase the lability of messenger RNA.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=246333Documentos Relacionados
- Killer of Saccharomyces cerevisiae: a double-stranded ribonucleic acid plasmid.
- Messenger ribonucleic acid and protein metabolism during sporulation of Saccharomyces cerevisiae.
- Influence of pH on the rate of ribosomal ribonucleic acid synthesis during sporulation in Saccharomyces cerevisiae.
- Ribonucleic acid synthesized in meiotic cells of Saccharomyces cerevisiae: effect of culture medium pH.
- Nature of Ribonucleic Acid Synthesis During Early Sporulation in Saccharomyces cerevisiae
